We have extensive experience in manufacturing of a broad range of viral vector-based therapies and can support development of your programme with innovative solutions and state-of-the art technology platforms.
Our approach is platform-agnostic and is based on applying internal know-how acquired over years of experience.
With a strong technical background and sustained by a regulatory track record in process development, scale-up and GMP manufacturing of viral vectors for use in multitude of therapy indications, our expertise is extensive and includes Vaccines, Oncolytic Viruses (OV), Gene Therapy products, and other Immunotherapies.
